Aaron Green Buys 36,650 Shares of OneMedNet (NASDAQ:ONMD) Stock

OneMedNet Corporation (NASDAQ:ONMD) CEO Aaron Green acquired 36,650 shares of the business’s stock in a transaction on Tuesday, June 23rd. The stock was purchased at an average cost of $0.57 per share, with a total value of $20,890.50. Following the acquisition, the chief executive officer directly owned 1,896,375 shares of the company’s stock, valued at $1,080,933.75. This represents a 1.97% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink.

Aaron Green also recently made the following trade(s):

• On Monday, June 15th, Aaron Green bought 18,702 shares of OneMedNet stock. The shares were purchased at an average cost of $0.54 per share, for a total transaction of $10,099.08.
• On Friday, June 12th, Aaron Green bought 36,920 shares of OneMedNet stock. The shares were purchased at an average cost of $0.56 per share, for a total transaction of $20,675.20.

OneMedNet Stock Down 7.3%

NASDAQ:ONMD opened at $0.59 on Friday. OneMedNet Corporation has a 52 week low of $0.44 and a 52 week high of $4.22. The stock’s 50-day moving average price is $0.82 and its 200-day moving average price is $0.90. The stock has a market capitalization of $31.85 million, a PE ratio of -11.70 and a beta of 1.12.

OneMedNet (NASDAQ:ONMD) last released its quarterly earnings results on Friday, May 15th. The company reported ($0.04) earnings per share for the quarter. The company had revenue of $0.10 million during the quarter.

Analysts Set New Price Targets

ONMD has been the topic of a number of recent analyst reports. Weiss Ratings reiterated a “sell (e+)” rating on shares of OneMedNet in a research report on Monday, June 1st. Wall Street Zen cut shares of OneMedNet from a “hold” rating to a “sell” rating in a research report on Saturday, May 23rd. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, OneMedNet has a consensus rating of “Sell”.

Institutional Investors Weigh In On OneMedNet

Large investors have recently bought and sold shares of the company. Jane Street Group LLC acquired a new stake in shares of OneMedNet in the fourth quarter worth approximately $119,000. Exencial Wealth Advisors LLC increased its position in shares of OneMedNet by 1.3% during the fourth quarter. Exencial Wealth Advisors LLC now owns 3,644,861 shares of the company’s stock worth $4,009,000 after purchasing an additional 45,401 shares in the last quarter. Virtu Financial LLC acquired a new position in OneMedNet in the 4th quarter valued at $48,000. State Street Corp raised its stake in OneMedNet by 41.5% in the 4th quarter. State Street Corp now owns 116,700 shares of the company’s stock valued at $128,000 after purchasing an additional 34,200 shares during the last quarter. Finally, HRT Financial LP purchased a new position in OneMedNet in the 4th quarter valued at $32,000. 0.95% of the stock is currently owned by hedge funds and other institutional investors.

About OneMedNet

OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.